Ausgabe Sonderheft 2/2005
Basic science, rationale, background and future of abatacept
Inhalt (4 Artikel)
Modulating co-stimulation: a rational strategy in the treatment of rheumatoid arthritis?
Vivianne Malmström, Christina Trollmo, Lars Klareskog
The evolving clinical profile of abatacept (CTLA4–Ig): a novel co-stimulatory modulator for the treatment of rheumatoid arthritis
Eric M Ruderman, Richard M Pope
The role of the T cell in autoimmune inflammation
Alla Skapenko, Jan Leipe, Peter E Lipsky, Hendrik Schulze-Koops